Tag: COPD
GSK and Empirico ink US$745 million deal on experimental COPD drug
Global biopharma company GSK has entered a worldwide exclusive license agreement with US-based clinical-stage biotechnology company Empirico for EMP-012, an experimental small interfering RNA (siRNA) therapy being tested for chronic obstructive pulmonary disease (COPD). The deal includes an US$85 million […]
China Expands Public Health Program; Adds COPD to Raise Awareness, Diagnosis
China has added chronic obstructive pulmonary disease (COPD) to its basic public health service program, a move that is expected to raise awareness and improve treatment capabilities at the grassroots level. COPD, a chronic condition that impairs airflow and breathing, […]
